Toxicokinetic measurements within genotoxicity assays are a necessity, not a nuisance. Both in vitro and in vivo tests stand to gain from the inclusion of kinetic considerations. This paper describes the rationale for using toxicokinetics in genotoxicity tests, and provides examples.
MitchellIDeG. Noscapine-induced Polyploidy in vitro. Mutagenesis. 1991;6: 479–486.
2.
EllardSMohammedYDograSWoelfelCDoehmerJParryJM. The use of genetically engineered V79 Chinese hamster cultures expressing rat liver CYP1A1, 1A2, 2B1 cDNAs in micronucleus assays. Mutagenesis. 1991;6: 461–470.
3.
SeilerJP. The mutagenicity of benzimidazole and benzimidazole derivatives. VI. Cytogenetic effects of benzimidazole derivatives in the bone marrow of the mouse and the Chinese hamster. Mutation Res. 1976;40: 339–348.
4.
SeilerJP. Apparent and Real Thresholds. In: ScottDBridgesBASobelsFH, eds. Progress in Genetic Toxicology. Amsterdam: Elsevier/North-Holland Biomedical Press; 1977:233–238.
